The increasing prevalence of cancer globally is expected to drive the growth of the radiation therapy market. As the incidence of various types of cancer rises, the demand for radiation therapy as a treatment option is also expected to increase. Additionally, technological advancements in radiation therapy techniques and equipment is expected to drive market growth. These advancements have led to more precise and effective treatment options, attracting a larger patient population.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Type, Technology, Application, Procedure, End-User |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Nordion Inc, Siemens healthcare, Mevion medical system, Inc, Isoray, Inc, Icad, Inc, Becton Dickinson and Company, Ion Beam Appications SA, Elekta AB, Eckert & Zeigler Group, Accuray Incorporated, Varian Medical Syatems, Inc, NTP Radioisotopes SOC, Curium Pharma, C.R.BARD , Inc, IBA Radiopharma Solutions, ViewRay, Inc, P-cure, ZEISS Group, Panacea Medical Technologies, Hitachi |
The high cost of radiation therapy treatment poses a major restraint to market growth. The high cost of equipment, maintenance, and treatment itself can be a barrier for many patients seeking radiation therapy. Additionally, the limited availability of skilled professionals in the field of radiation therapy is another major restraint. The shortage of trained personnel can limit the capacity of healthcare facilities to provide radiation therapy treatment, thus hindering market growth.